[back to company universe](https://highsignal.app/case-studies)

Developer tools

# FidoCure®

Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. Our veterinary partners h

sources

2

Evidence entries preserved.

affiliations

2

Andreessen Horowitz, Y Combinator

competitors

6

Mapped from High Signal graph features.

status

generated

artifact cache

last updated

2026-07-15

17:19 UTC

source evidence

Why this company exists here

## Y Combinator

yc-company-directory #3858

[official source](https://www.ycombinator.com/companies/fidocure)

## Andreessen Horowitz

a16z-investment-list #340

[official source](https://a16z.com/investment-list/)

generated read

High Signal interpretation

FidoCure® is classified as **Developer tools** from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.

offline extraction

Product facets

FidoCure®veterinary medicinegenetic sequencingtargeted therapiesPrecision medicine

mapping method

Similarity graph

Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.

discovery cluster

## Companies similar to FidoCure®

Developer tools · 6 peers

A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.

[### Yemaachi Biotechnology match 62Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones. With our research activities based in Africa, we are able to leverage access to the most genetically diverse population on the planet to build a first-of-its-kinshared product terms: cancer, research, precision, sequenc; shared product theme: health and clinical care; shared affiliation: Y Combinator](https://highsignal.app/case-studies/yemaachi-biotechnology)[### Shield Bio match 56Shield Bio is a precision medicine company with a proprietary platform that enables reliable nanopore sequencing in under a minute, in a clinical setting. It is focused on bringing 3rd generation or "nanopore" sequencing into clinical use to deliver on the promise of precision medicine. Shield is initially using the technology to improve the treatment of infectious disease and address the unmet clinical need of sepsis, which kills 300,000 people a year in the US alone.shared extracted concept terms: sequenc; shared product terms: disease, precision, medicine, bring; shared product theme: health and clinical care; shared affiliation: Andreessen Horowitz, Y Combinator](https://highsignal.app/case-studies/shield-bio)[### Miphic match 49Miphic enables the switch from long and expensive drug development to mitochondrial precision medicine that saves the lives of blood cancer patients.shared extracted concept terms: medicine, precision; shared product terms: cancer, precision, medicine; shared product theme: health and clinical care](https://highsignal.app/case-studies/miphic)[### ParcelBio match 49ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.shared product terms: disease, medicine, therapie, oncology; shared product theme: health and clinical care; same category: Developer tools; shared affiliation: Y Combinator](https://highsignal.app/case-studies/parcelbio)[### Meta-Flux match 47Meta-Flux is an AI-assisted detection diagnostics platform for disease prevention. Its Patterns and fluctuations seen in personalized medicine can identify diseases. Using Artificial Intelligence and designing computer software offers a service that ca...shared extracted concept terms: medicine; shared product terms: disease, medicine, offer, diagnostic; shared product theme: health and clinical care](https://highsignal.app/case-studies/meta-flux)[### Syndicate Bio match 44Empowering Personalized Healthcare and Advancing Precision Medicineshared extracted concept terms: medicine, precision; shared product terms: precision, medicine, empower](https://highsignal.app/case-studies/syndicate-bio)

---

Canonical HTML: https://highsignal.app/case-studies/fidocure